Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

RECRUITING

Empowering Mothers in the NICU

Lead Sponsor:

University of Yalova

Conditions:

Mothers

Premature

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

Family Integrated Care is designed to eliminate the barriers between parents and their infants in the NICU by involving parents of premature infants in their care. Parents are integrated into both the...

Eligibility Criteria

Inclusion

  • The newborn must be premature (gestational age \>28 and \<34 weeks),
  • The infant must be admitted to the NICU and hospitalized for at least 3 days,
  • The mother must be open to communication and cooperation,
  • The mother must voluntarily agree to participate in the study,
  • The mother must be literate,
  • The mother must be able to speak and understand Turkish,
  • The mother must be primiparous and experiencing motherhood for the first time,
  • The mother must be over 18 years of age,
  • Mothers in the intervention group must be present in the hospital for an average of 6-8 hours per day.

Exclusion

  • The newborn has a congenital anomaly (e.g., craniofacial anomalies such as cleft palate, cleft lip, or facial muscle paralysis),
  • The newborn has a diagnosed gastrointestinal, neurological, or genetic disorder (e.g., necrotizing enterocolitis, hydrocephalus, Down syndrome, omphalocele, gastroschisis, short bowel syndrome, or other diseases),
  • The newborn has a congenital heart defect requiring surgical intervention,
  • The mother has a diagnosed psychiatric illness,
  • The mother and/or father do not wish to participate in the study.
  • Withdrawal Criteria:
  • The mother does not attend the training sessions during the study period,
  • The mother fails to maintain cooperation throughout the study,
  • The newborn is transferred to another healthcare center for any reason,
  • The mother wishes to withdraw from the study,
  • The newborn is diagnosed with a chronic illness during the study process.

Key Trial Info

Start Date :

August 30 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

54 Patients enrolled

Trial Details

Trial ID

NCT06958458

Start Date

August 30 2025

End Date

December 1 2025

Last Update

September 18 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Yalova University

Yalova, Turkey (Türkiye), 77200